Progyny Price to Free Cash Flow Ratio 2018-2025 | PGNY

Progyny price to free cash flow ratio from 2018 to 2025. Price to free cash flow ratio can be defined as

Progyny Price to Free Cash Flow Ratio 2018-2025 | PGNY

Progyny price to free cash flow ratio from 2018 to 2025. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$146.1B
CVS Health (CVS)$78.8B
Elevance Health (ELV)$66.1B
Cencora (COR)$56.6B
DiDi Global (DIDIY)$24.2B
Labcorp Holdings (LH)$22.1B
Natera (NTRA)$19.2B
BioMerieux (BMXMF)$17.1B
EUROFINS SCIENT (ERFSF)$14.9B
ICON (ICLR)$14.7B
CochLear (CHEOY)$13.3B
Solventum (SOLV)$12.6B
Medpace Holdings (MEDP)$12.3B
Revvity (RVTY)$10.7B
Viatris (VTRS)$10.6B
Avantor (AVTR)$9.4B
Sonic Healthcare (SKHHY)$8.9B
Charles River Laboratories (CRL)$8.7B
HealthEquity (HQY)$8.5B
Caris Life Sciences,�Inc (CAI)$7.5B
Bausch + Lomb (BLCO)$4.9B
Amplifon S.p.A (AMFPF)$3.9B
BrightSpring Health Services (BTSG)$3.7B
Sotera Health (SHC)$3.4B
GeneDx Holdings (WGS)$3B
Surgery Partners (SGRY)$2.9B
Concentras Parent (CON)$2.6B
Organon (OGN)$2.6B
Alignment Healthcare (ALHC)$2.6B
Premier (PINC)$1.8B